Caponnetto, Valeria
Russo, Antonio
Silvestro, Marcello
Tessitore, Alessandro
De Icco, Roberto
Vaghi, Gloria
Sances, Grazia
Tassorelli, Cristina
Baraldi, Carlo
Castro, Flavia Lo
Guerzoni, Simona
Prudenzano, Maria Pia
Fallacara, Adriana
Gentile, Martino
Ornello, Raffaele
Onofri, Agnese
Burgalassi, Andrea
Chiarugi, Alberto
De Cesaris, Francesco
Granato, Antonio
Casalena, Alfonsina
De Tommaso, Marina
Mampreso, Edoardo
Merlo, Paola
Coppola, Gianluca
Battistini, Stefania
Rebecchi, Valentina
Rainero, Innocenzo
Sepe, Federica Nicoletta
Dalla Volta, Giorgio
Sacco, Simona
Geppetti, Pierangelo
Iannone, Luigi Francesco http://orcid.org/0000-0003-3598-0195
Allena, Marta
Brovia, Daria
Liaci, Giorgio
Tabasso, Giorgio
Vigani, Giulia
Garascia, Gabriele
Manganotti, Paolo
La Porta, Anna
Beretta, Natascia
Tronci, Stefano
Baiata, Claudio
,
Funding for this research was provided by:
Università degli Studi di Firenze
Article History
Accepted: 25 October 2023
First Online: 24 November 2023
Declarations
:
: Open access funding provided by Università degli Studi di Firenze within the CRUI-CARE Agreement.
: Pierangelo Geppetti received personal fees from Allergan, Eli Lilly, Novartis, Amgen, and TEVA; grants from Amgen, TEVA, Eli-Lilly, Allergan, and Chiesi; is on the Scientific Advisory Board for Endosome Therapeutics; and is a founding scientist of FloNext srl, Spinoff of the University of Florence. Francesco De Cesaris received personal fees from TEVA, Eli Lilly, and Novartis. Luigi Francesco Iannone received personal fees from Eli-Lilly and TEVA, and a travel grant from Lundbeck. Simona Sacco reports personal fees as a speaker or advisor from Abbott, Allergan-AbbVie, AstraZeneca, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, and Teva, and research grants from Novartis. Raffaele Ornello reports personal fees from Novartis, Eli Lilly, and Teva, and non-financial support from Novartis, Allergan, Eli Lilly, and Teva. Simona Guerzoni received personal fees from Allergan/AbbVie, Eli Lilly, Novartis, Teva, and Lundbeck. Carlo Baraldi received fees and honoraria from Eli-Lilly, TEVA, Allergan/AbbVie, Lundbeck, and Novartis. Grazia Sances received personal fees as a speaker or was on the Advisory Board for Eli-Lilly, Novartis, TEVA, Lundbeck, and Pfizer. Roberto De Icco received honoraria for scientific presentations from Eli-Lilly and Teva. Gloria Vaghi received travel grants from Lundbeck and TEVA. Marta Allena received personal fees as a speaker from Eli Lilly. N.G. received personal fees as a speaker from Eli Lilly. Valeria Caponnetto, Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Cristina Tassorelli, Grazia Sances, Flavia Lo Castro, Simona Guerzoni, Maria Pia Prudenzano, Adriana Fallacara, Martino Gentile, Agnese Onofri, Andrea Burgalassi, Alberto Chiarugi, Antonio Granato, Alfonsina Casalena, Marina De Tommaso, Edoardo Mampreso, Paola Merlo, Gianluca Coppola, Stefania Battistini, Valentina Rebecchi, Innocenzo Rainero, Federica Nicoletta Sepe, and Giorgio Dalla Volta have no conflicts of interest that are directly relevant to the content of this article.
: The study was approved as a part of the Registro Italiano Cefalee (RICe) study by the local ethics committee (Studio RICe, 14591_oss and subsequent emendaments).
: Informed consent was obtained from each patient.
: Not applicable.
: Data supporting the findings in the present study are reported in the article and in the supplementary materials. The raw data collected and analyzed are available from the corresponding author on reasonable request.
: Not applicable.
: All authors critically reviewed the manuscript, agreed to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.